Fundraising Fox

Fennecpharma

Research Triangle Park, US · 1 known investors

fennecpharma.com ↗

Fennec Pharmaceuticals is a biotechnology company focused on treatments for cancer patients who experience hearing loss caused by chemotherapy. It develops product-specific therapies for the US market.

BiotechHealthtechin /fennecpharma@FennecPharma

Founders & leadership

AH
Adrian HaighDirector
SS
Steven SkolskyDirector
CR
Chris RallisDirector
KL
Krysia LynesExecutive Officer
RR
Rostislav RaykovExecutive Officer, Director
KI
Khalid IslamDirector

Investors · 1

Avoro Capital AdvisorsNew York

Reported raises · per SEC filings

Form D private placements
▶$7.6MraisedJun 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adrian HaighDirector
  • Steven SkolskyDirector
  • Chris RallisDirector
  • Krysia LynesExecutive Officer
  • Rostislav RaykovExecutive Officer, Director
  • Khalid IslamDirector
Offering amount
$7.6M
Amount sold
$7.6M
First sale
Jun 2017
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.